Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2018 09:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Sponsors Clinical Research Forum on Ending Opioid Epidemic

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
May 30, 2018 09:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, May 30, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
May 10, 2018 08:30 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis

- Vitality’s GI-targeted VBX-100 THC compound to be investigated as treatment of recurrent C. difficile infections LOS ANGELES, May 10, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
April 05, 2018 09:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D

-Wholly-owned subsidiary to enable access to best available cannabinoid compounds in a federally-compliant manner and facilitate key collaborative research programs LOS ANGELES, April 05, 2018 ...
March 28, 2018 08:30 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide

THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
March 19, 2018 08:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter

LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
January 17, 2018 08:00 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100

LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
January 03, 2018 08:30 ET | Source: Vitality Biopharma, Inc

Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC

LOS ANGELES, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
November 01, 2017 07:00 ET | Source: Vitality Biopharma, Inc.

Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals

LOS ANGELES, CA--(Marketwired - Nov 1, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid...
October 19, 2017 07:00 ET | Source: Vitality Biopharma, Inc.

Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD

LOS ANGELES, CA--(Marketwired - Oct 19, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug...